Pantheon International PLC
Rated Fund 2013-19. A fund-of-funds approach with a spread of risk and reward
Pantheon International was launched in 1987, making it the UK’s longest-established private equity fund of funds. It has grown from £12 million at launch to £1.4 billion today.
Since its inception, it has generated average annual net asset value per share growth of 11.9%, outperforming both the FTSE All-Share (7.8%) and MSCI World (7.9%) indices.
The lead manager is Andrew Lebus, who heads a team of 80 investment professionals. He actively manages risk by carefully selecting high-quality private equity managers to create a balanced portfolio that is diversified by geography, investment stage and sector. Exposure is balanced across buyout, venture and growth, and special situations funds.
Some 43% of the portfolio is invested in secondary investments (buying interests from other investors), which allow the managers to maintain a mature portfolio profile and benefit from the cash distributions that gives the trust its financial strength and investment pace.
Co-investments (participating directly in the purchase of a portfolio company investment alongside a private equity fund) have increased in recent years, from 3% in 2013 to 32% today. These are undertaken alongside private equity managers that are already known to Pantheon and have successful track records of managing assets through economic cycles. The balance is in primary investments (investing in a new fund when it is established).
At the end of 2018, the portfolio was weighted towards the US (56%) and Europe (25%). Its shares have traded on a discount to net assets as wide as 30% and as narrow as 12% in the past three years.
Narrative and ratings content all as of 01 January 2019.See all Money Observer rated funds
|Eusa Pharma||2.20 %|
|Abacus Data Systems||1.20 %|
|Adyen NV||1.00 %|
|LBX Pharmacy Chain JSC||0.80 %|
|Permian Res||0.80 %|
|Orangefield Group||0.70 %|
|Kyobo Life Insurance||0.60 %|
|United States||44.44 %|
|United Kingdom||14.81 %|
|Asia - Emerging||14.81 %|
|Consumer Defensive||30.95 %|
|Financial Services||16.67 %|
|Consumer Cyclical||11.90 %|
Data provided by Morningstar.
The Content is only for your general information and use and is not intended to address your particular requirements. The Content does not constitute any form of advice, recommendation or arrangement by Money Observer and is not intended to be relied upon by you in making (or refraining from making) any specific investment or other decisions. Appropriate independent advice should be obtained before making any such decision.
This information is sourced from our partner Morningstar. We believe the data to be correct however you should take care in using any information.
You should be aware that prices may fall as well as rise and that the income derived can go down as well as up. When buying or selling any investment that fluctuates in price or value you may get back less than you invested. Past performance is not necessarily a guide to future performance.